Medicare Enrolled
Dr. Eric Frechette, M.D.
Epilepsy Physician · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Frechette from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frechette?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Frechette
Dr. Eric Frechette is an epilepsy physician in Arcadia, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Frechette performed 3,880 Medicare services across 2,237 unique beneficiaries.
Between the years covered by Open Payments, Dr. Frechette received a total of $25,293 from 74 pharmaceutical and/or device companies across 1306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Frechette is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in CA
$25,293 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,880
Medicare services
Top 10% in CA for epilepsy physician
2,237
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,495 | $106 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,063 | $150 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
273 | $67 | $125 |
| New patient office visit, complex (60-74 min) | 222 | $184 | $350 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
198 | $411 | $560 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
188 | $79 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
143 | $100 | $175 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
114 | $89 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
96 | $146 | $300 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
27 | $100 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $157 | $300 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $189 | $350 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
14 | $120 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $79 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,293
Total received (2018-2024)
Avg $3,613/year across 7 years
Top 17% in CA for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,306
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,983 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$310 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,160
2023
$3,611
2022
$3,820
2021
$3,753
2020
$2,881
2019
$3,238
2018
$3,831
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$1,221
SK Life Science, Inc.
$372
Eisai Inc.
$243
Neurocrine Biosciences, Inc.
$232
Lilly USA, LLC
$227
PFIZER INC.
$215
ABBVIE INC.
$165
Lundbeck LLC
$161
Kyowa Kirin, Inc.
$150
Teva Pharmaceuticals USA, Inc.
$146
Otsuka America Pharmaceutical, Inc.
$139
Grifols USA, LLC
$134
ARGENX US, INC.
$94
Celgene Corporation
$91
MDD US Operations, LLC
$89
Neurelis, Inc.
$87
Alexion Pharmaceuticals, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$54
Amneal Pharmaceuticals LLC
$52
CATALYST PHARMACEUTICALS, INC.
$51
LivaNova USA, Inc.
$32
AstraZeneca Pharmaceuticals LP
$25
Octapharma USA, Inc.
$21
Merz Pharmaceuticals, LLC
$19
Azurity Pharmaceuticals, Inc.
$15
ACADIA Pharmaceuticals Inc
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
HARMONY BIOSCIENCES LLC
$14
Top 3 companies account for 44.1% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$4,181
Teva Pharmaceuticals USA, Inc.
$1,601
SK Life Science, Inc.
$1,155
Neurocrine Biosciences, Inc.
$1,152
Alexion Pharmaceuticals, Inc.
$967
ABBVIE INC.
$898
Lilly USA, LLC
$872
Lundbeck LLC
$855
Greenwich Biosciences, Inc.
$805
Amgen Inc.
$787
Supernus Pharmaceuticals, Inc.
$690
ACADIA Pharmaceuticals Inc
$655
PFIZER INC.
$575
Sunovion Pharmaceuticals Inc.
$525
JAZZ PHARMACEUTICALS INC.
$498
Avanir Pharmaceuticals, Inc.
$480
Grifols USA, LLC
$447
Eisai Inc.
$436
Biogen, Inc.
$406
Takeda Pharmaceuticals U.S.A., Inc.
$364
US WorldMeds, LLC
$342
Otsuka America Pharmaceutical, Inc.
$337
ARGENX US, INC.
$326
Kyowa Kirin, Inc.
$311
LivaNova USA, Inc.
$298
Amneal Pharmaceuticals LLC
$293
Allergan, Inc.
$277
Novartis Pharmaceuticals Corporation
$255
Corium, LLC
$250
Harmony Biosciences LLC
$249
Medtronic, Inc.
$242
Abbott Laboratories
$242
AbbVie Inc.
$235
AstraZeneca Pharmaceuticals LP
$223
MDD US Operations, LLC
$221
Neurelis, Inc.
$195
EISAI INC.
$175
GENZYME CORPORATION
$167
CATALYST PHARMACEUTICALS, INC.
$161
Celgene Corporation
$160
Biohaven Pharmaceutical Holding Company Ltd.
$160
CSL Behring
$153
Acorda Therapeutics, Inc
$148
Adamas Pharmaceuticals, Inc.
$147
Biohaven Pharmaceuticals, Inc.
$129
HARMONY BIOSCIENCES LLC
$104
Travere Therapeutics, Inc.
$94
Retrophin, Inc.
$86
Alnylam Pharmaceuticals Inc.
$79
Allergan Inc.
$78
Sumitomo Pharma America, Inc.
$73
EMD Serono, Inc.
$66
Bausch Health US, LLC
$59
E.R. Squibb & Sons, L.L.C.
$52
Upsher-Smith Laboratories LLC
$50
Janssen Pharmaceuticals, Inc
$45
Catalyst Pharmaceuticals, Inc.
$43
UPSHER-SMITH LABORATORIES LLC
$41
Zogenix Inc.
$40
AQUESTIVE THERAPEUTICS, INC.
$37
Vertical Pharmaceuticals, LLC
$33
Medtronic USA, Inc.
$33
Zyla Life Sciences
$32
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$30
GRT US Holding, Inc.
$23
Octapharma USA, Inc.
$21
Merz Pharmaceuticals, LLC
$19
GE Healthcare
$19
Jazz Pharmaceuticals Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$17
Ceribell, Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Arbor Pharmaceuticals, Inc.
$13
Egalet US Inc
$12
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Andexxa · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRINTELLIX · Banzel · Briviact · COMIRNATY · COPAXONE · CREXONT · Cenobamate · Ceribell Rapid Response EEG · Cholbam · DUOPA · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · LifeVest · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · QULIPTA · Qutenza · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WELLBUTRIN · Wakix · XADAGO · XCOPRI · Xadago · Xeomin · Xyrem · ZAVZPRET · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Epilepsy physicians within 10 mi
3
Per 100K population
0.0
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Frechette is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Frechette experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Frechette performed 1,495 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frechette receive payments from pharmaceutical companies?
Yes. Dr. Frechette received a total of $25,293 from 74 companies across 1,306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frechette's costs compare to other epilepsy physicians in Arcadia?
Dr. Frechette's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frechette) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Epilepsy Physicians in Arcadia
Browse epilepsy physicians in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in CA
Epilepsy physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in CA
Which CA epilepsy physicians receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology